Expression, purification, and characterization of deglycosylated human pro-prostate-specific antigen

Protein Expression and Purification

Volumn 20, Issue 3, 2000, Pages 405-413

  Bowman, Krista K ^a   Clark, Jim ^a   Yu, Lily ^a   Mortara, Kyle ^a   Radika, Kesavan ^b   Wang, Jing ^b   Zhan, Hangjun ^a  

^a Department of Protein Expression ^*  (United States)

^b Axys Pharmaceuticals Inc   (United States)

Author keywords

Deglycosylation; proPSA; Prostate specific antigen; PSA; Purification; Recombinant expression

Indexed keywords

CHO CELL; DEGLYCOSYLATION; FLUID; GEL FILTRATION; IN VITRO CULTURE; MOLECULAR WEIGHT; PROSTATE SPECIFIC ANTIGEN; WILD RELATIVE; X RAY CRYSTALLOGRAPHY;

CRICETINAE; CRICETULUS GRISEUS;

EID: 0033667125     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1006/prep.2000.1342     Document Type: Article

References (41)

1. An adjustment to the 1997 estimate for new prostate cancer cases
2. Molecular forms of prostate-specific antigen and the human kallikrein gene family: A new era
3. Molecular cloning of human prostate specific antigen cDNA
4. Human prostate-specific antigen: Structural and functional similarity with serine proteases
5. The proteolytic activity of human prostate-specific antigen
6. In situ hybridization of prostate-specific antigen mRNA in human prostate
7. Prostate antigen: A new potential marker for prostatic cancer
8. A kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein
9. Prostate-specific antigen (PSA) is an insulin-like growth factor binding protein-3 protease found in seminal plasma
10. Prostate specific antigen cleaves parathyroid hormone-related protein in the PTH-like domain: Inactivation of PTHrP-stimulated cAMP accumulation in mouse osteoblasts
11. Prostate-specific antigen, a serine protease, facilitates human prostate cancer cell invasion
12. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate
13. A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: Assay of the complex improves clinical sensitivity for cancer
14. Prostate-specific antigen in serum occurs predominantly in complex with alpha 1-antichymotrypsin
15. Serum prostate specific antigen complexed to alpha 1-antichymotrypsin as an indicator of prostate cancer
16. Molecular mass and carbohydrate structure of prostate specific antigen: Studies for establishment of an international PSA standard
17. hGK-1: A kallikrein gene expressed in human prostate
18. Purification of enzymatically active kallikrein hK2 from human seminal plasma
19. Seminal plasma protein p30: Simplified purification and evidence for identity with prostate specific antigen
20. Identity of prostate specific antigen and the semen protein P30 purified by a rapid chromatography technique
21. Dual-label one-step immunoassay for simultaneous measurement of free and total prostate-specific antigen concentrations and ratios in serum
22. Free, complexed and total serum prostate specific antigen: The establishment of appropriate reference ranges for their concentrations and ratios
23. Immunofluorometric assay for sensitive and specific measurement of human prostatic glandular kallikrein (hK2) in serum
24. Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors
25. Prostatic kallikrein hK2, but not prostate-specific antigen (hK3), activates single-chain urokinase-type plasminogen activator
26. The chymotrypsin-like activity of human prostate-specific antigen, gamma-seminoprotein
27. Isolation and characterization of a semen-specific protein from human seminal plasma: A potential new marker for semen identification
28. Purification and characterization of different molecular forms of prostate-specific antigen in human seminal fluid
29. Expression of pro form of prostate-specific antigen by mammalian cells and its conversion to mature, active form by human kallikrein 2
30. Production of recombinant PSA and hK2 and analysis of their immunologic cross-reactivity
31. Expression of active, secreted human prostate-specific antigen by recombinant baculovirus-infected insect cells on a pilot-scale
32. Generation, purification, and characterization of a recombinant source of human prostate-specific antigen
33. Characterization of the precursor of prostate-specific antigen: Activation by trypsin and by human glandular kallikrein
34. Modeling of prostate specific antigen and human glandular kallikrein structures
35. A structural model for the prostate disease marker, human prostate-specific antigen
36. Structural comparison of prostate-specific antigen and human glandular kallikrein using molecular modeling
37. Structural investigation of the alpha-1-antichymotrypsin: Prostate-specific antigen complex by comparative model building
38. Characterization of prostate-specific antigen proteolytic activity on its major physiological substrate, the sperm motility inhibitor precursor/semenogelin I
39. Expression of the mouse dihydrofolate reductase complementary deoxyribonucleic acid in simian virus 40 vectors
40. Role of N-glycosylation in the expression and functional properties of human AT1 receptor